In Vitro Screening of Environmental Chemicals for Targeted Testing Prioritization: The ToxCast Project

Abstract

BackgroundChemical toxicity testing is being transformed by advances in biology and computer modeling, concerns over animal use, and the thousands of environmental chemicals lacking toxicity data. The U.S. Environmental Protection Agency’s ToxCast program aims to address these concerns by screening and prioritizing chemicals for potential human toxicity using in vitro assays and in silico approaches.ObjectivesThis project aims to evaluate the use of in vitro assays for understanding the types of molecular and pathway perturbations caused by environmental chemicals and to build initial prioritization models of in vivo toxicity.MethodsWe tested 309 mostly pesticide active chemicals in 467 assays across nine technologies, including high-throughput cell-free assays and cell-based assays, in multiple human primary cells and cell lines plus rat primary hepatocytes. Both individual and composite scores for effects on genes and pathways were analyzed.ResultsChemicals displayed a broad spectrum of activity at the molecular and pathway levels. We saw many expected interactions, including endocrine and xenobiotic metabolism enzyme activity. Chemicals ranged in promiscuity across pathways, from no activity to affecting dozens of pathways. We found a statistically significant inverse association between the number of pathways perturbed by a chemical at low in vitro concentrations and the lowest in vivo dose at which a chemical causes toxicity. We also found associations between a small set of in vitro assays and rodent liver lesion formation.ConclusionsThis approach promises to provide meaningful data on the thousands of untested environmental chemicals and to guide targeted testing of environmental contaminants.

EPAs methodology to inform TSCA pre-manufacturing notification decision-making: a critical analysis based on chemicals regulated by consent order

“…Second, it is generally accepted that alternative methods can potentially result in significant cost savings over traditional, in vivo methods (van Der et al, 2004). Finally, alternative methods can be carried out more quickly and the same test can be carried out on a multitude of chemicals simultaneously (Judson et al, 2010). TSCA requires evaluation of PMN submissions within 90 days, necessitating the use of methods like analogue analysis and in silico, so that information can be quickly generated to inform decisions.…”

Breath biomarkers in toxicology

“…The ultimate goal for toxicity testing is to use this technology to probe for changes in the baseline respiration patterns of cell cultures (bacterial, animal, human) upon administration of potentially toxic substances. The magnitude of the observed perturbations in vitro could be compared to the applied dose to prioritize chemicals for more detailed in vivo toxicity testing to complement current high-throughput tests at the molecular level (Judson et al 2010;Tice et al 2013). …”

Toxicogenomics for transcription factor-governed molecular pathways: moving on to roles beyond classification and prediction

“…Toxicogenomics is an enabling technology in all of these endeavors. The US EPA's ToxCast initiative (Judson et al 2010) has emphasized prioritization. A suite of Fig.…”